FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Oct 28, 2022
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on October 28, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- October 28, 2022
- Product Type
- Biologics
View Company Profile
ID · 968d9f06-bf5e-4cdd-9935-7488a2e7e9c9
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1191447
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Octapharma Plasma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 23, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 21, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 2, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 6, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1015098 - 2017-05-23
- FDA Inspection 935859 - 2015-07-23
- FDA Inspection 819769 - 2013-02-21
- FDA Inspection 722288 - 2011-05-02
- FDA Inspection 660401 - 2010-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.